Skip to Content

Nanobac Pharmaceuticals Inc NNBP

Morningstar Rating
$0.00 0.00 (0.00%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

NNBP is trading at a 537% premium.
Price
$0.00
Fair Value
$1.49
Uncertainty
Extreme
1-Star Price
$8.52
5-Star Price
$8.75
Economic Moat
Fxyqwx
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if NNBP is a good fit for your portfolio.

Trading Information

Previous Close Price
$0.00
Day Range
$0.000.00
52-Week Range
$0.000.00
Bid/Ask
$0.00 / $0.00
Market Cap
$249.51
Volume/Avg
500 / 750

Key Statistics

Price/Earnings (Normalized)
Price/Sales
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Nanobac Pharmaceuticals Inc is a research-based, bio-lifescience company. The Company is primarily engaged in the discovery and development of products and services to improve peoples health through the detection and treatment of Calcifying Nanoparticles.
Sector
Healthcare
Industry
Biotechnology
Stock Style Box
Small Core
Total Number of Employees
10

Valuation

Metric
NNBP
Price/Earnings (Normalized)
Price/Book Value
Price/Sales
Price/Cash Flow
Price/Earnings
No chart available

Financial Strength

Metric
NNBP
Quick Ratio
0.00
Current Ratio
0.00
Interest Coverage
Quick Ratio
No chart available

Profitability

Metric
NNBP
Return on Assets (Normalized)
−87.53%
Return on Equity (Normalized)
Return on Invested Capital (Normalized)
−251.02%
Return on Assets
No chart available
See how this stock stacks up to its competitors with Morningstar Investor

Biotechnology Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Novo Nordisk A/S ADR
NVO
HzwnrhdcvBzcqv$589.6 Bil
Vertex Pharmaceuticals Inc
VRTX
VbzcmgpcCbswl$126.9 Bil
Regeneron Pharmaceuticals Inc
REGN
PdyjqgsMtbftf$117.2 Bil
Moderna Inc
MRNA
HsxmtmqGvsq$46.4 Bil
Alnylam Pharmaceuticals Inc
ALNY
CnhwkhjmWfxjry$30.1 Bil
argenx SE ADR
ARGX
KzjggdwsFbmz$28.0 Bil
BioNTech SE ADR
BNTX
JldsqwrfyVxbw$20.6 Bil
Biomarin Pharmaceutical Inc
BMRN
QhnqpynMcxndy$16.0 Bil
United Therapeutics Corp
UTHR
BsmkqsbtnGzlhz$14.6 Bil
Incyte Corp
INCY
RnxkzksyRmmpfs$13.0 Bil

Sponsor Center